Using cancer or pre-cancer subject sequencing data and a database of therapy biomarker distributions to determine normalized biomarker scores and generate a graphical user interface
First Claim
1. A system, comprising:
- at least one computer hardware processor;
at least one database that stores biomarker information; and
at least one non-transitory computer-readable storage medium storing processor-executable instructions that, when executed by the at least one computer hardware processor, cause the at least one computer hardware processor to perform;
obtaining sequencing data about at least one biological sample of a subject known to have or suspected of having cancerous cells or pre-cancerous cells;
accessing, in the at least one database, biomarker information indicating a distribution of values for each biomarker in at least a reference subset of a plurality of biomarkers across a respective group of people, each of the plurality of biomarkers being associated with at least one therapy in a plurality of therapies, the plurality of biomarkers including a first biomarker and the biomarker information including a first distribution of values for the first biomarker;
determining, using both the sequencing data and the biomarker information;
a first set of normalized scores for a first set of biomarkers associated with a first therapy in the plurality of therapies, anda second set of normalized scores for a second set of biomarkers associated with a second therapy in the plurality of therapies,wherein determining the first set of normalized scores comprises determining a first normalized score for the first biomarker at least in part by determining a statistical score for the first biomarker based on the first distribution of values for the first biomarker;
determining, using the first set of normalized scores and second set of normalized scores, respective first and second therapy scores for the first and second therapies;
generating a graphical user interface (GUI) that comprises;
a first portion associated with the first therapy in the plurality of therapies, the first portion including a first plurality of GUI elements, each of the first plurality of GUI elements being associated with a respective biomarker in the first set of biomarkers and having at least one visual characteristic determined based on a normalized score of the respective biomarker in the first set of normalized scores;
a second portion associated with the second therapy in the plurality of therapies, the second portion including a second plurality of GUI elements different from the first plurality of GUI elements, each of the second plurality of GUI elements being associated with a respective biomarker in the second set of biomarkers and having at least one visual characteristic determined based on a normalized score of the respective biomarker in the second set of normalized scores; and
displaying the generated GUI.
2 Assignments
0 Petitions
Accused Products
Abstract
Techniques for generating therapy biomarker scores and visualizing same. The techniques include determining, using a patient'"'"'s sequence data and distributions of biomarker values across one or more reference populations, a first set of normalized scores for a first set of biomarkers associated with a first therapy, and a second set of normalized scores for a second set of biomarkers associated with a second therapy, generating a graphical user interface (GUI) including a first portion associated with the first therapy and having at least one visual characteristic determined based on a normalized score of the respective biomarker in the first set of normalized scores; and a second portion associated with a second therapy and having at least one visual characteristic determined based on a normalized score of the respective biomarker in the second set of normalized scores; and displaying the generated GUI.
-
Citations
30 Claims
-
1. A system, comprising:
-
at least one computer hardware processor; at least one database that stores biomarker information; and at least one non-transitory computer-readable storage medium storing processor-executable instructions that, when executed by the at least one computer hardware processor, cause the at least one computer hardware processor to perform; obtaining sequencing data about at least one biological sample of a subject known to have or suspected of having cancerous cells or pre-cancerous cells; accessing, in the at least one database, biomarker information indicating a distribution of values for each biomarker in at least a reference subset of a plurality of biomarkers across a respective group of people, each of the plurality of biomarkers being associated with at least one therapy in a plurality of therapies, the plurality of biomarkers including a first biomarker and the biomarker information including a first distribution of values for the first biomarker; determining, using both the sequencing data and the biomarker information; a first set of normalized scores for a first set of biomarkers associated with a first therapy in the plurality of therapies, and a second set of normalized scores for a second set of biomarkers associated with a second therapy in the plurality of therapies, wherein determining the first set of normalized scores comprises determining a first normalized score for the first biomarker at least in part by determining a statistical score for the first biomarker based on the first distribution of values for the first biomarker; determining, using the first set of normalized scores and second set of normalized scores, respective first and second therapy scores for the first and second therapies; generating a graphical user interface (GUI) that comprises; a first portion associated with the first therapy in the plurality of therapies, the first portion including a first plurality of GUI elements, each of the first plurality of GUI elements being associated with a respective biomarker in the first set of biomarkers and having at least one visual characteristic determined based on a normalized score of the respective biomarker in the first set of normalized scores; a second portion associated with the second therapy in the plurality of therapies, the second portion including a second plurality of GUI elements different from the first plurality of GUI elements, each of the second plurality of GUI elements being associated with a respective biomarker in the second set of biomarkers and having at least one visual characteristic determined based on a normalized score of the respective biomarker in the second set of normalized scores; and displaying the generated GUI. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13)
-
-
12. The system of 1, wherein each of the plurality of biomarkers is selected from the group consisting of:
- a genetic biomarker, a cellular biomarker, a saccharide biomarker, a lipid biomarker, a heterocyclic biomarker, an elementary compound biomarker, an imaging biomarker, an anthropological biomarker, a personal habit biomarker, a disease-state biomarker, and an expression biomarker.
-
14. At least one non-transitory computer-readable storage medium storing processor-executable instructions that, when executed by the at least one computer hardware processor, cause the at least one computer hardware processor to perform:
-
obtaining sequencing data about at least one biological sample of a subject known to have or suspected of having cancerous cells or pre-cancerous cells; accessing, in at least one database, biomarker information indicating a distribution of values for each biomarker in at least a reference subset of a plurality of biomarkers across a respective group of people, each of the plurality of biomarkers being associated with at least one therapy in a plurality of therapies, the plurality of biomarkers including a first biomarker and the biomarker information including a distribution of values for the first biomarker; determining, using both the sequencing data and the biomarker information; a first set of normalized scores for a first set of biomarkers associated with a first therapy in the plurality of therapies, and a second set of normalized scores for a second set of biomarkers associated with a second therapy in the plurality of therapies, wherein determining the first set of normalized scores comprises determining a first normalized score for the first biomarker at least in part by determining a statistical score for the first biomarker based on the first distribution of values for the first biomarker; determining, using the first set of normalized scores and second set of normalized scores, respective first and second therapy scores for the first and second therapies; generating a graphical user interface (GUI) that comprises; a first portion associated with the first therapy in the plurality of therapies, the first portion including a first plurality of GUI elements, each of the first plurality of GUI elements being associated with a respective biomarker in the first set of biomarkers and having at least one visual characteristic determined based on a normalized score of the respective biomarker in the first set of normalized scores; a second portion associated with the second therapy in the plurality of therapies, the second portion including a second plurality of GUI elements different from the first plurality of GUI elements, each of the second plurality of GUI elements being associated with a respective biomarker in the second set of biomarkers and having at least one visual characteristic determined based on a normalized score of the respective biomarker in the second set of normalized scores; and displaying the generated GUI. - View Dependent Claims (15, 16, 17, 18, 19, 20, 21, 22)
-
-
23. A method, comprising:
-
obtaining sequencing data about at least one biological sample of a subject known to have or suspected of having cancerous cells or pre-cancerous cells; accessing, in at least one database, biomarker information indicating a distribution of values for each biomarker in at least a reference subset of a plurality of biomarkers across a respective group of people, each of the plurality of biomarkers being associated with at least one therapy in a plurality of therapies, the plurality of biomarkers including a first biomarker and the biomarker information including a distribution of values for the first biomarker; determining, using both the sequencing data and the biomarker information; a first set of normalized scores for a first set of biomarkers associated with a first therapy in the plurality of therapies, and a second set of normalized scores for a second set of biomarkers associated with a second therapy in the plurality of therapies, wherein determining the first set of normalized scores comprises determining a first normalized score for the first biomarker at least in part by determining a statistical score for the first biomarker based on the first distribution of values for the first biomarker; determining, using the first set of normalized scores and second set of normalized scores, respective first and second therapy scores for the first and second therapies; generating a graphical user interface (GUI) that comprises; a first portion associated with the first therapy in the plurality of therapies, the first portion including a first plurality of GUI elements, each of the first plurality of GUI elements being associated with a respective biomarker in the first set of biomarkers and having at least one visual characteristic determined based on a normalized score of the respective biomarker in the first set of normalized scores; a second portion associated with the second therapy in the plurality of therapies, the second portion including a second plurality of GUI elements different from the first plurality of GUI elements, each of the second plurality of GUI elements being associated with a respective biomarker in the second set of biomarkers and having at least one visual characteristic determined based on a normalized score of the respective biomarker in the second set of normalized scores; and displaying the generated GUI. - View Dependent Claims (24, 25, 26, 27, 28, 29, 30)
-
Specification